Hyderabad: As part of the Quad Vaccine Partnership, United States International Development Finance Corporation (DFC) will expand financial assistance for $ 50 million for Hyderabad-based biological E Ltd to help vaccine makers increase their capacity to produce more than 1 billion doses of Covid-19 vaccine on At the end of 2022.
DFC Head of DFC David Marchick and Biological Managing Director E Mahima Datla would sign a dashed line on Monday in Hyderabad.
FORMALIZATION The financing agreement came more than six months after the US government announced his decision to expand assistance to Indian vaccine makers after the Quad leader Summit, was held virtually in March 2021.
Quad is an informal strategic forum consisting of India, USA.
, Japan and Australia aim to fight China’s growing influence in the Indo-Pacific region.
Biological E has been issued by the US Pharma Mayor Johnson & Johnson to produce more than 500 million doses of Covid-19 vaccine per year.
J & J has signed a pact on August 2020 to make a dose of Janssen Covid-19 vaccine Janssen-19 in India.
Biological Implementing Director E Datla has told TI earlier that Quad initiatives will offer “extensive support for BIO E to increase capacity” Good for J & J vaccines and which developed with the Baylor College of Medicine based in Houston after getting the world of organizational prequalification Health.